T. Prasad Sahoo

Treatment of advanced non-small-cell lung cancer

Kumar Prabhash, Amish Vora, Sewanti Limaye et al. · Cancer Research Statistics and Treatment · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A Double-Blind, Randomized, Placebo-Controlled, Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib (SOR) in Combination with Paclitaxel (PAC) as a First-Line Therapy in Patients (pts) with Locally Recurrent or Metastatic Breast Cancer (BC).

William J. Gradishar, Virginia Kaklamani, T. Prasad Sahoo et al. · Cancer Research · 2009 · 37 citations

Medicine, Oncology, Pharmacology +14

Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing

Kumar Prabhash, Suresh H. Advani, Ullas Batra et al. · Advances in Therapy · 2019 · 24 citations

Medicine, Molecular Biology, Oncology +15

Abstract P2-16-03: Sorafenib in Combination with Paclitaxel as a First-Line Therapy in Patients with Locally Recurrent or Metastatic Breast Cancer: Overall Survival Results from a Double-Blind, Randomized, Placebo-Controlled, Phase 2b Trial

Shailesh Bondarde, Virginia Kaklamani, T. Prasad Sahoo et al. · Cancer Research · 2010 · 15 citations

Medicine, Oncology, Pharmacology +17